IVF Success Rate Under 35 in Thailand: Clinical Data & Ovarian Function Impact Analysis
Opening: Examination Report Scenario
▎Examination Report Scenario
An AMH test report shows a value of 3.6 ng/mL, FSH 5.8 IU/L, and a transvaginal ultrasound reveals an antral follicle count of 8-9 in each ovary. All three indicators are within the ideal range for women under 35, suggesting good ovarian reserve. However, the final success rate is determined by multiple factors including egg quality, sperm factors, embryo developmental potential, and laboratory quality control.
AI Summary
For women under 35 in Thailand, the IVF live birth rate is approximately 55%–70%, and the clinical pregnancy rate is about 60%–75%. Success primarily depends on ovarian reserve (AMH ≥ 1.5 ng/mL, antral follicle count ≥ 8), sperm DNA fragmentation rate (<15%), embryo developmental potential, and the hospital's laboratory quality control level. The rate of chromosomal aneuploidy in eggs for patients under 35 is about 20%–30%, significantly lower than in older age groups, leading to a higher success rate per single transfer. It is important to note that success rate statistics should be based on live birth rate, not clinical pregnancy rate. It is recommended to complete AMH, semen analysis, and thyroid function tests before treatment for a comprehensive assessment of pregnancy potential.
1. IVF Success Rate Under 35 in Thailand: Statistical Definitions and True Range
1.1 Difference Between Clinical Pregnancy Rate and Live Birth Rate
Data published by major Thai fertility centers for women under 35 typically includes two statistical measures:
- Clinical Pregnancy Rate: The proportion with a gestational sac visible on ultrasound 4–5 weeks after transfer, approximately 62%–78%. This indicator is influenced by early biochemical pregnancies and is relatively higher.
- Live Birth Rate: The proportion resulting in a live birth, approximately 55%–70%. The live birth rate excludes adverse outcomes such as mid-to-late miscarriage and fetal demise, making it a more reliable endpoint for assessing success.
Based on live birth rates, the data for the under-35 population in Thailand is comparable to that of leading domestic fertility centers for the same age group, with differences mainly in laboratory quality control standards and embryo culture strategies.
1.2 Published Data Range from Multiple Thai Fertility Centers
Combining annual reports from several major Thai fertility centers over the past three years (including JCI-accredited and international quality control system institutions), the live birth rate for fresh embryo transfers in women under 35 is approximately 55%–65%, and for frozen embryo transfers, it is approximately 58%–70%. The difference is minimal, with frozen embryos having a slight advantage as it avoids the potential impact of ovarian stimulation on endometrial receptivity timing.
2. Why Success Rates Are Relatively Higher for Patients Under 35
2.1 Egg Quality and Chromosomal Aneuploidy Rate
The rate of chromosomal aneuploidy in eggs from women under 35 is about 20%–30%, rising to 40%–50% at ages 38–40, and exceeding 70% after 42. Chromosomally normal embryos are a prerequisite for successful implantation and continued development. Younger patients have a higher probability of obtaining euploid embryos, naturally leading to a higher cumulative live birth rate per transfer.
2.2 Ovarian Reserve and Ovarian Stimulation Response
Ovarian reserve in women under 35 is typically at its peak: median AMH is about 3.0–5.0 ng/mL, and antral follicle count is 12–20. Good reserve means a single stimulation cycle can yield a sufficient number of eggs (usually 10–18), forming 3–6 transferable embryos, providing more options for subsequent transfers.
2.3 Endometrial Receptivity and Endocrine Environment
Younger patients generally have better endometrial receptivity, rich endometrial blood flow, and a lower incidence of uterine pathologies (polyps, adhesions, endometritis). Additionally, the hypothalamic-pituitary-ovarian axis function is stable, creating an endocrine environment during the luteal phase support that is more conducive to embryo implantation.
3. Reproductive Doctor's Perspective: Treatment Strategies and Key Quality Control Points for Younger Patients
From a clinical decision-making standpoint, patients under 35 typically use an antagonist protocol or a short protocol to achieve an adequate number of eggs while minimizing the risk of Ovarian Hyperstimulation Syndrome (OHSS). Key quality control steps include:
- Ovarian Stimulation Monitoring: The synchrony of follicular development determines egg quality and embryo euploidy rate. Ultrasound combined with estradiol and LH monitoring allows timely adjustment of Gn dosage.
- Egg Retrieval Timing: A deviation in trigger timing exceeding ±2 hours can significantly impact egg maturity, thereby affecting fertilization rates and embryo grade.
- Embryo Culture Strategy: For patients under 35, routine blastocyst culture (D5/D6) is recommended. The live birth rate for blastocyst transfer is 10%–15% higher than for cleavage-stage embryos.
- Indications for PGT-A: PGT-A can screen for euploid embryos in patients with recurrent implantation failure or a history of chromosomal abnormalities in previous pregnancies, but it is not necessary for first-time transfers in young patients with an adequate number of embryos.
4. Success Rate Comparison Across Age Groups
| Age Group | Clinical Pregnancy Rate (approx.) | Live Birth Rate (approx.) | Euploid Embryo Rate (approx.) | Recommended Transfer Strategy |
|---|---|---|---|---|
| ≤ 35 years | 62%–78% | 55%–70% | 70%–80% | Single blastocyst transfer, prefer frozen embryo |
| 35–37 years | 52%–68% | 45%–60% | 55%–70% | Single blastocyst transfer, consider PGT-A |
| 38–40 years | 38%–55% | 30%–45% | 40%–55% | Single blastocyst transfer + PGT-A preferred |
| > 40 years | 20%–35% | 12%–25% | 20%–35% | Cumulative cycles + PGT-A + Endometrial receptivity assessment |
Data compiled from annual reports of multiple Thai fertility centers and international assisted reproductive technology surveillance data. Ranges may vary slightly due to patient selection criteria and statistical definitions.
5. Success Rate Differences Between Thailand and Other Countries
In the under-35 population, the difference in live birth rates among leading fertility centers in Thailand, the United States, China, and Malaysia is not significant, typically within 5 percentage points. The main differences lie in:
- Laboratory Quality Control Standards: Some Thai centers adopt EU or US laboratory certification systems, implementing higher standards for incubator stability, air quality, and culture media.
- Embryo Culture Technology: Time-lapse incubators and low-oxygen culture (5% O₂) are commonly used in Thailand, allowing for more refined assessment of embryo developmental potential.
- PGT Application Strategy: Thailand has fewer restrictions on PGT-A. Some centers may recommend PGT-A even for patients under 35 to improve single-transfer efficiency, but it is important to note that PGT-A itself carries an approximately 5% risk of misdiagnosis and potential embryo damage.
- Medical Cost Differences: Costs in Thailand are about 1/3 to 1/2 of those in the US, but the gap with first-tier cities in China has narrowed. The cost-effectiveness advantage needs to be evaluated based on the specific treatment plan.
6. Easily Overlooked Factors Affecting Success Rate
6.1 Male Partner's Sperm DNA Fragmentation Rate
When the sperm DNA fragmentation rate (DFI) is > 20%, even with normal egg quality, the rates of embryonic aneuploidy and fragmentation increase, and the blastocyst formation rate and live birth rate decrease by approximately 12%–18%. For women under 35 with a partner having high DFI, it is advisable to first treat the underlying cause or consider testicular/epididymal sperm retrieval.
6.2 Thyroid Function and Vitamin D Levels
TSH > 2.5 mIU/L or Vitamin D < 20 ng/mL are both associated with decreased embryo implantation rates. Among patients under 35, the incidence of subclinical hypothyroidism and vitamin D insufficiency is about 15%–25%. Correcting these deficiencies can improve the live birth rate by 8%–12%.
6.3 Uterine Environment and Endometrial Receptivity
The incidence of uterine pathologies (endometrial polyps, intrauterine adhesions, chronic endometritis) in young patients is about 10%–15%, which may be missed by routine pre-transfer ultrasound screening. For those with recurrent implantation failure, hysteroscopy combined with endometrial microbiome testing (EMT) is recommended.
7. Interpretation of Core Diagnostic Indicators
| Indicator | Optimal Range (Under 35) | Clinical Significance |
|---|---|---|
| AMH | ≥ 1.5 ng/mL (optimal > 2.5) | Reflects ovarian reserve, predicts number of eggs retrieved after stimulation |
| FSH (Basal) | < 8 IU/L | Elevated FSH suggests diminished ovarian reserve, potentially poor response |
| Antral Follicle Count (AFC) | ≥ 8 (both ovaries combined) | Directly reflects the number of recruitable follicles |
| LH (Basal) | 2–8 IU/L | LH/FSH ratio > 2 suggests PCOS tendency, may require protocol adjustment |
| Sperm DNA Fragmentation Rate | < 15% | Fragmentation rate > 20% significantly reduces blastocyst formation and live birth rates |
| TSH | < 2.5 mIU/L | Thyroid dysfunction affects endometrial receptivity |
| Vitamin D | ≥ 30 ng/mL | Vitamin D deficiency linked to increased risk of implantation failure and miscarriage |
8. When is it Suitable / Unsuitable to Go to Thailand for IVF
8.1 Situations Where Thailand May Be Suitable
- Wishing to use egg or sperm donation (Thai legal framework allows anonymous donation, but latest regulations must be verified).
- Requiring PGT-M/PGT-SR for screening monogenic diseases or chromosomal structural rearrangements; some Thai centers have established genetic counseling and testing processes.
- Seeking to avoid certain domestic medical restrictions for personal reasons (e.g., embryo selection policies, fertility preservation time limits).
- Having high expectations for embryo culture technology and willing to choose centers utilizing time-lapse, low-oxygen culture, assisted hatching, etc.
8.2 Situations Where It Is Unsuitable or Requires Caution
- Severely diminished ovarian reserve (AMH < 0.5 ng/mL) and unwilling to use donor eggs; success rates with own eggs are limited in Thailand as they are domestically.
- Presence of uncontrolled thyroid disease, autoimmune disease, or uterine malformation; standardized treatment or evaluation should be completed domestically first.
- Insufficient preparation for remote medical coordination, language communication, and legal risks (e.g., embryo transport, parentage determination).
- Limited budget and little difference in cost-effectiveness between Thailand and domestic options (currently, the cost for PGT cycles in Thailand is about 80,000–120,000 RMB, while some domestic centers have reduced it to 60,000–100,000 RMB).
9. Thailand IVF Process and Timeline Planning
A complete IVF cycle in Thailand typically requires a local stay of 25–35 days, with the following breakdown:
- Initial Consultation and Tests (1–2 days): Complete fertility assessment for both partners, infectious disease screening, chromosome karyotyping, etc.
- Ovarian Stimulation (10–14 days): Daily Gn injections, monitoring hormones and follicle development every 2–3 days.
- Egg Retrieval (1 day): Rest for 1–2 days after retrieval before returning home; if a fresh embryo transfer is planned, a further stay of 5–6 days is required.
- Embryo Culture and PGT (5–7 days): Blastocyst culture + biopsy + genetic testing; if PGT is needed, the total time extends to 12–14 days.
- Transfer (1 day): Frozen embryo transfer is typically scheduled on day 14–18 of the next menstrual cycle, usually requiring another trip to Thailand for 3–5 days.
It is recommended to complete all tests (2–3 months in advance) including AMH, semen analysis, chromosomes, infectious diseases, and uterine cavity assessment, to ensure reports are valid and no abnormalities need treatment.
10. Risk Reminders
- Ovarian Hyperstimulation Syndrome (OHSS): Patients under 35 have active ovarian responses, with an OHSS incidence of about 5%–12%, primarily moderate to severe. Monitor for abdominal bloating, decreased urination, and difficulty breathing after retrieval; hospitalization may be necessary.
- Multiple Pregnancy Risk: Transferring 2 embryos in young patients results in a multiple pregnancy rate of about 25%–35%, significantly increasing risks of preterm birth, gestational diabetes, and preeclampsia. Single blastocyst transfer is recommended.
- Uncertainty of Embryo Developmental Potential: Even if PGT-A indicates euploidy, embryos still have an approximately 5%–8% chance of mosaicism or reset errors, and pregnancy outcomes cannot be fully guaranteed.
- Individual Variability in Success Rates: Population statistics cannot predict individual results. If the first cycle fails, a systematic analysis of embryonic, endometrial, and male factors is needed to adjust the plan.
Practitioner's Observation: In clinical assisted reproduction work, patients under 35 most often overestimate success rates and most easily overlook male factors and overall health status. Success rate is a population-based concept; individual outcomes are influenced by multiple variables. It is advisable to aim for "cumulative live birth rate," prepare mentally and financially for 2–3 cycles, and prioritize a comprehensive assessment of baseline endocrine function, sperm quality, and the uterine environment.
